Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus
Previous studies suggest that low bone mass is a potential complication of insulin-dependent diabetes mellitus. Nevertheless, the factors that influence diabetic osteopenia are not well established. In order to evaluate the prevalence and magnitude of diabetic osteopenia and its association with clinical and metabolic variables, we studied 94 consecutive patients with insulin-dependent diabetes mellitus. Their age ranged from 20 to 56 years and duration of diabetes varied from 1 to 35 years. Bone mineral density (BMD) was measured by dual X-ray absorptiometry at lumbar spine and proximal femur and the values were expressed as z-score. The presence and extent of microvascular complications, degree of metabolic control, and other risk factors for osteoporosis were recorded and some biochemical markers of bone metabolism were assessed. Diabetic patients showed reduced BMD in all sites (lumbar spine: −0.89±1.21; femoral neck: −0.99±1.24; Ward triangle; −1.05±1.24;P<0.0001). Of the 94 patients 19.1% met diagnostic criteria for osteoporosis. BMD correlated with body mass index in all sites and with the duration of disease in Ward's triangle. Presence and extent of diabetic complications were associated with lower BMD, as was smoking. No correlation was found between BMD and biochemical markers. In conclusion, osteopenia is a common complication in patients with insulin-dependent diabetes mellitus. Microvascular complications are a critical point in the progression of diabetic osteopenia. Other risk factors for osteoporosis (nutritional status and smoking) must be taken into account.
Key wordsInsulin-dependent diabetes mellitus Bone mineral density Dual X-ray absorptiometry Bone turnover markers Microvascular complications
Unable to display preview. Download preview PDF.
- 3.Compston JE, Smith EM, Matthews C, Schofield P (1994) Whole body composition and regional bone mass in women with insulin-dependent diabetes mellitus. Clin Endocrinol 41: 289–293Google Scholar
- 7.Craig R, Rowe D, Kream B (1984) Regulation of bone collagen synthesis and procollagen mRNA levels by insulin. Calcif Tissue Int 36:557–561Google Scholar
- 8.Muñoz-Torres M, Díaz Pérez de Madrid J, Escobar Jiménez F, Ortego N, González A, García-Calvente C (1991) Alterations of mineral metabolism in type 1 (insulin-dependent) diabetic patients (abstract). Diabetologia 34(suppl 2):A164Google Scholar
- 9.Verrotti A, Chiarelli F, Capani F, Morgese G (1992) Calcium metabolism in type I diabetes mellitus. Diabetes Nutr Metab 5:231–236Google Scholar
- 10.Brownlee M (1990) Collagen changes in diabetes: basic aspects and clinical implications. In: Belfiore F, Molinatti GM, Reaven GM (eds) Tissue-specific metabolic alterations in diabetes. Karger Gmbh, Bassel, pp 54–60Google Scholar
- 18.World Health Organization Study Group (1985) Diabetes Mellitus. World Health Organization Technical Reports Series No. 727, GenevaGoogle Scholar
- 19.Díaz Curiel M, Castro N (1992) Bone mineral density in the Spanish population measured by dual X-ray absorptiometry (DEXA) (abstract). Bone Miner 17(suppl 1):133Google Scholar
- 20.World Health Organization Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization Technical Reports Series No. 843, GenevaGoogle Scholar